Definitive Healthcare (DH) Scheduled to Post Earnings on Tuesday

Definitive Healthcare (NASDAQ:DHGet Free Report) is set to release its earnings data after the market closes on Tuesday, May 7th. Analysts expect Definitive Healthcare to post earnings of $0.08 per share for the quarter. Persons that are interested in registering for the company’s earnings conference call can do so using this link.

Definitive Healthcare (NASDAQ:DHGet Free Report) last posted its quarterly earnings data on Wednesday, February 28th. The company reported ($0.01) earnings per share for the quarter, missing analysts’ consensus estimates of $0.01 by ($0.02). The company had revenue of $65.93 million for the quarter, compared to analyst estimates of $66.01 million. Definitive Healthcare had a positive return on equity of 0.43% and a negative net margin of 80.40%. On average, analysts expect Definitive Healthcare to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Definitive Healthcare Stock Up 0.6 %

DH stock opened at $7.03 on Monday. Definitive Healthcare has a 52 week low of $5.53 and a 52 week high of $12.45. The company has a quick ratio of 2.31, a current ratio of 2.31 and a debt-to-equity ratio of 0.20. The firm has a 50-day simple moving average of $7.85 and a 200-day simple moving average of $8.31. The stock has a market capitalization of $828.06 million, a P/E ratio of -3.95, a P/E/G ratio of 6.12 and a beta of 1.41.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on DH shares. Stifel Nicolaus cut their price objective on Definitive Healthcare from $12.00 to $11.00 and set a “buy” rating for the company in a research note on Wednesday, January 17th. Needham & Company LLC cut shares of Definitive Healthcare from a “buy” rating to a “hold” rating in a research note on Wednesday, January 17th. Canaccord Genuity Group increased their price target on Definitive Healthcare from $9.00 to $10.00 and gave the company a “hold” rating in a report on Thursday, February 29th. Finally, Barclays boosted their price objective on Definitive Healthcare from $10.00 to $11.00 and gave the stock an “equal weight” rating in a research note on Friday, March 1st. Seven equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, Definitive Healthcare has a consensus rating of “Hold” and an average price target of $11.31.

Get Our Latest Stock Analysis on Definitive Healthcare

Definitive Healthcare Company Profile

(Get Free Report)

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.

Featured Articles

Earnings History for Definitive Healthcare (NASDAQ:DH)

Receive News & Ratings for Definitive Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Definitive Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.